← back to search

Michael J. Gait

National Institute of Standards and Technology · US
Area of research
Molecular Biology
Research interest
Research focused on Dystrophin and Duchenne muscular dystrophy, with related work in Nucleic acid, Cell biology, Oligonucleotide. Notable publications include 'Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy', 'How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse', and 'Self-Assembly into Nanoparticles Is Essential for Receptor Mediated Uptake of Therapeutic Antisense Oligonucleotides'.
h-index
citations
512
works
9
NIH funding
primary concept
email

Recent publications

Dystrophin involvement in peripheral circadian SRF signalling
Life Science Alliance 2021cited by 8position: middledoi
Dystrophin regulates peripheral circadian SRF signalling
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 0position: middledoi
Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular Atrophy
Methods in molecular biology 2019cited by 10position: middledoi
How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the<i>mdx</i>mouse
Human Molecular Genetics 2015cited by 135position: middledoi
Self-Assembly into Nanoparticles Is Essential for Receptor Mediated Uptake of Therapeutic Antisense Oligonucleotides
Nano Letters 2015cited by 96position: middledoi
Incorporation of Modified Nucleotides into RNA for Studies on RNA Structure, Function and Intermolecular Interactions
ASM Press eBooks 2014cited by 5position: middledoi
Nucleic acids: new life, new materials
Organic & Biomolecular Chemistry 2013cited by 8position: firstdoi
Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy
Molecular Therapy — Nucleic Acids 2012cited by 154position: middledoi
Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
Molecular Therapy — Nucleic Acids 2012cited by 96position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Matthew J. A. Wood · University of Oxford7 papers (2012–2021) · 5 papers (2012–2021) · 4 papers (2012–2021)Samir EL Andaloussi · Karolinska University Hospital4 papers (2012–2015) · 3 papers (2012–2015) · 3 papers (2012–2015) · 3 papers (2015–2021) · 2 papers (2021–2021)Subhashis Banerjee · The University of Texas Southwestern Medical Center2 papers (2021–2021)John R. Counsell · UK Dementia Research Institute2 papers (2021–2021)F. Foster · University of Manchester2 papers (2021–2021) · 2 papers (2015–2015)Amarjit Bhomra · Johannes Gutenberg University Mainz2 papers (2021–2021)Alessandra Ferlini · University of Ferrara2 papers (2021–2021) · 2 papers (2021–2021)Maria Sofia Falzarano · University of Ferrara2 papers (2021–2021)Jennifer E. Morgan · Nationwide Children's Hospital2 papers (2021–2021) · 2 papers (2015–2019) · 2 papers (2021–2021) · 2 papers (2021–2021)